Foghorn Therapeutics Inc. (FHTX)

NASDAQ: FHTX · Real-Time Price · USD

1.890

+0.040 (2.16%)

At close: Oct 15, 2026, 4:00 PM EDT

1.860

-0.030 (-1.59%)

After-hours: Oct 15, 2026, 7:30 PM EDT

Foghorn Therapeutics Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Foghorn Therapeutics stock has a consensus rating of "Buy" and an average price target of $4.17. The average 1-year stock price forecast is 120.63% higher than the current stock price, while the lowest is $2.00 (+5.82%) and the highest is $5.00 (+164.55%).

Price Target: $4.17 (+120.63%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$2.00	$4.17	$5.00	$5.00
Change	+5.82%	+120.63%	+164.55%	+164.55%

Analyst Ratings

The average analyst rating for Foghorn Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	9	9	9	9	9	5
Buy	1	1	1	1	1	0
Hold	0	0	0	0	0	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Gavin Clark-Gartner Evercore ISI	Evercore ISI	Hold Downgrades $14 → $3	Hold	Downgrades	$14 → $3	+58.73%	Oct 13, 2026
Unknown Analyst Guggenheim No rating	Guggenheim	Buy Maintains $12 → $5	Buy	Maintains	$12 → $5	+164.55%	Oct 2, 2026
Robert Driscoll Wedbush	Wedbush	Hold Downgrades $10 → $2	Hold	Downgrades	$10 → $2	+5.82%	Oct 2, 2026
Andres Y. Maldonado H.C. Wainwright	H.C. Wainwright	Buy Reiterates $13 → $5	Buy	Reiterates	$13 → $5	+164.55%	Oct 2, 2026
Jeet Mukherjee BTIG	BTIG	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Oct 1, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

28.71M

from 30.91M

-7.10%

from 30.91M

Revenue Next Year

33.30M

from 28.71M

15.98%

from 28.71M

EPS This Year

-0.93

from -1.21

EPS Next Year

-1.03

from -0.93

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.32M	19.23M	34.16M	22.60M	30.91M	28.71M
Revenue Growth	206.74%	1,357.77%	77.63%	-33.83%	36.75%	-7.10%
Operating Income	-100.73M	-117.14M	-107.91M	-100.29M	-82.11M	-69.33M
Net Income	-101.32M	-108.88M	-98.43M	-86.62M	-74.28M	-61.09M
EPS	-	-	-	-	-1.21	-0.93
Free Cash Flow	-	-	-	-	-86.15M	-68.81M
No. Analysts	-	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	44.3M
Avg	28.7M
Low	19.3M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	43.3%
Avg	-7.1%
Low	-37.6%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.70
Avg	-0.93
Low	-1.22

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-